COV NTAUB NTAWV - Nyob rau lub Kaum Hli 5, 2005 cov ntaub ntawv yees duab tib neeg taug kev los ntawm Boots lub tsev muag tshuaj hauv plawv nroog London. Drugstore chain Walgreen Co. hais tias nws yuav siv $ 6.7 nphom los yuav ib feem ntawm cov khw muag khoom noj qab haus huv thiab kev zoo nkauj Alliance Boots. (AP Duab / Sergio Dionisio)
Sergio Dionisio
Walgreens Boots Alliance CEO Roz Brewer tau hais rau hnub Tuesday tias cov khw muag khoom tau pib qhov kev tshuaj xyuas zoo ntawm nws cov khau lag luam.
Hauv kev nthuav qhia virtual ntawm JP Morgan Lub Rooj Sib Tham Kev Noj Qab Haus Huv, Brewer tau lees paub tias lub tuam txhab tab tom txiav txim siab yuav ua li cas nrog UK-raws li cov khw muag tshuaj. Nws tsis tau hais tias qhov ntawd yuav yog qhov muag thiab, yog tias muaj, leej twg yuav yog tus yuav.
Nws tau hais tias "Thaum cov txheej txheem nyob rau theem tshawb nrhiav, peb cia siab tias yuav txav mus sai," nws hais.
Walgreens tau tshaj tawm tias xav txog kev muag khoom, vim nws nce siab rau kev saib xyuas kev noj qab haus huv thiab sib tw nrog Asmeskas tus neeg sib tw CVS Health. Nyuam qhuav pib hnub Tuesday, British xov xwm tshaj tawm Sky News tau tshaj tawm tias cov tuam txhab kev ncaj ncees ntiag tug Bain Capital thiab CVC Capital Partners tau muab tso ua ke kev sib tw rau Boots. Nws tau hais txog cov peev txheej uas tsis muaj npe thiab Walgreens tsis tau hais tawm hauv tsab ntawv tshaj tawm.
Cov khau khau muaj ntau dua 2,200 lub khw muag khoom thiab kwv yees li 51,000 tus neeg ua haujlwm, raws li lub tuam txhab lub vev xaib. Nws kuj muaj ntau pua qhov kev coj ua kho qhov muag thiab qhov chaw saib xyuas hnov lus. Nrog rau kev muag khoom hauv khw muag tshuaj, nws paub txog cov npe zoo nkauj, suav nrog nws tus kheej cov ntawv xws li No7 thiab Soap & Glory, uas tau khaws los ntawm cov khw muag khoom loj xws li Ulta Beauty thiab Walmart.
Shares ntawm Walgreens kaw ntawm $ 54.33 rau hnub Tuesday, nce 1.12% thiab nce txog 14% hauv 12 lub hlis dhau los.
Tau qhov twg los: https://www.cnbc.com/2022/01/11/walgreens-ceo-weighing-strategic-options-for-uk-based-boots.html